Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Liposuction study reveals hidden blood risks

NCT ID NCT04656054

Knowledge-focused Sponsor: Alaa Hassan M. Elhawary Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study looked at 20 women who had large-volume liposuction (5–8 liters) to see how removing fat from different body surface areas affects hemoglobin, clotting, and electrolyte levels. The goal was to understand safety risks better. The study did not test a new treatment but aimed to gather knowledge for safer procedures.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
liposuction (procedure)
What this could lead to
If successful, this could help surgeons better understand how to reduce risks during large-volume liposuction.
What could go wrong
This is a very small, completed study (20 participants) that only observes changes—it does not test a new treatment or offer direct patient benefit.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

20 people

The number who actually took part.

Started

Nov 2020

Finished

Feb 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

To assess the impact of amount, up to 8 litres, versus surface area of liposuction on haematological parameters, coagulopathy profile and electrolyte balance.

Ages

25 to 45 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Female patient. 2. Age: 25-45 years. 3. BMI \<40 4. Large volume liposuction 5. Patient asking for liposuction or suction assisted lipoectomy. Exclusion Criteria: 1. Male patient. 2. Age \>45 or \<25 years. 3. Uncontrolled chronic diseases as DM, HTN. 4. Show degrees of lipodystropy at breast.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Lipodystrophy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

lipodystrophy Obesity obesity disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Lipodystrophy Obesity

Contacts and locations

Locations

  • Assuit University

    Asyut, Assuit, 71515, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.